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INTRODUCTION
What is Alzheimer’s Disease (AD)?
Alzheimer’s disease is an irreversible, progressive brain disorder that slowly 
destroys memory and thinking skills, and eventually, the ability to carry out the 
simplest tasks  (National Institute of Aging, 2016).
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SIGNIFICANCE
What’s in the news about the disease?
Biogen Inc. has halted trials on Alzheimer’s 
disease because of failed improvement.
https://www.statnews.com/2019/03/21/biogen-eisai-alzheimer-trial-stopped/
OBJECTIVES
To determine if Logical Memory Examination Test Scores can also be used to 
measure Alzheimer’s disease(AD).
To measure the longitudinal effect of apolipoprotein E epsilon 4 (APOE4) 
genotype on the logical memory test total score in AD.
To select the best model for measuring longitudinal changes in logical memory 
test score in linear mixed model analysis while controlling for the effects of sex 
and age.
STUDY DESIGN
Longitudinal study.
Data on study participants was obtained from the Alzheimer’s Disease 
Neuroimaging Initiative (ADNI).
METHODOLOGY
The study consisted of 2167 cognitive normal (CN) patients, 4472  mild cognitive 
impairment (MCI) and 844 Alzheimer’s Disease patients.
METHODOLOGY cont.
3309 females and 4174 males were monitored and their performance was 
recorded. 
Episodic memory of the study participants was monitored based on a short story 
told to the participants.
The participants were asked to recall what was told. 
ANALYSIS
Statistical analysis was done using SAS and graphical representations was done 
using Tableau.
The 7483 participants were monitored from baseline to 8 years down the line.
The mean age of the participants before the study was 74.0 years.
The mean age of the participants at the end of the study was 73.7 years.
98.5% of the participants with AD were APOE4 carriers. The corresponding rates 
of APOE4 carriers in  MCI and CN  groups were 97.34% and  98.3% respectively.
DATA MODELING
Table 1: Descriptive statistics
Variable CN MCI AD/DEMENTIA
Before                   After Before                 After Before                 After
Sample size(n) 2167                   2449 4472                    3118 844                   1647
Sex(%Female) 1069(49.33)   1265(56.25) 1867(41.75)   1235(39.61) 373(44.19)     707(42.93)
APOE4 carriers (%) 2130(98.3)     2332(95.22) 43.53(97.34)   3088(99.03) 831(98.46)      1636(99.33)
Mean Age ± SD 74.75(5.6)    73.79 (6.02) 72.3(6.82)         72.98(7.49) 75.05 (7.67)    74.31(7.37)
Education  ± SD 16.33(2.69)    16.43(2.64 ) 16.26 (2.66)       15.97(2.8) 15.16(2.98)      15.47(2.9)
LDELTOTAL  ± SD 13.58(4.38)     13.88(3.91) 9.13(4.23)           7.44(4.89) 1.06(2.01)          1.47(2.73)
DATA MODELING cont.
Table 2: Model selection
STRUCTURE AIC BIC Chi-Square P-value
Unstructured (UN) 37067.3 37438.1 7458.57 <.0001
Compound Symmetry (CS) 37771.3 37858.5 6650.57 <.0001
Autoregressive AR (1) 37659.5 37670.4 6755.98 <.0001
Heterogeneous ARH (1) 37596.9 37651.4 6834.58 <.0001
Heterogeneous CS 37565.3 37619.8 6866.2 <.0001
Variance Component 44413.5 44418.9 0 1
RESULTS
Fig. 1: Comparison between Minimal Mental State Examination Scores  
and Logical Memory Test Scores
RESULTS cont.
Fig. 2: Gender difference in Logical Memory Test Scores monitored for 9 
years
RESULTS cont.
Table 2: APOE4  was significantly associated with logical memory test scores       
(p-value <0.0001)  using linear mixed model analysis.
 The missing observations was 490.
Fig. 1: A positive relationship was observed from the plot of Logical Memory Test 
scores against Minimal Mental State Scores.
Fig. 2: Males obtained higher scores compared to females across all time points 
from the plot of time (viscode) against the logical memory scores.
CONCLUSION
The small p-value(p-value<0.0001) informs us that the logical memory 
examination scores is associated with APOE4 with the occurrence of Dementia. 
The positive relationship (fig. 1) indicates that logical memory examination scores 
have the ability just like the known MMSE score to detect whether a patient is at 
risk of getting Dementia.
The lower logical memory scores obtained for women at all time points (fig. 2) is 
an indication that females are more likely to be affected by Alzheimer’s Disease 
compared to males.
THE WAY FORWARD
Further research may be required to determine whether logical 
memory test score is better  than minimal mental state examination 
scores in predicting the transition from Alzheimer’s  Disease to 
Dementia.
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